Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics #00390

Submission Number:
00390
Commenter:
Maitri Mehta
State:
Florida
Initiative Name:
Understanding Competition in U.S. Prescription Drug Markets: Entry and Supply Chain Dynamics
Although drug prices are skyrocketing, non-PBM-owned pharmacies are being reimbursed drastically below cost. Meanwhile, PBMs force patients to use PBM-owned mail order and PBM-owned retail pharmacies (like CVS) in order to save on their copays. This is anticompetitive behavior that downgrades pharmacy and the seriousness of prescription medical treatment as if buying prescription drugs were the same as buying dish soap or paper towels ...